Liisa Bayko

Intercept Pharmaceuticals Inc (NASDAQ: ICPT) recently announced Jan. 7 that it expects to release top-line data from the interim analysis of the Phase 3 study dubbed "REGENERATE" during the first quarter.  The study is evaluating obeticholic acid in non-cirrhotic non-alcoholic...

Shares of Ultragenyx Pharmaceutical Inc (NASDAQ: RARE) tumbled more than 12 percent Wednesday after the company offered a disappointing update concerning a muscle-disease drug study. The biopharmaceutical company, which focuses on the development of novel products for rare and ultra-rare diseases,...

JMP has reiterated its Market Outperform rating on Retrophin Inc (NASDAQ: RTRX). The recently held expert call suggests recent DUET data for sparsentan are impressive, but JMP would like over a year's worth of data in order to see the full impact on disease progression. JMP hosted the call with...

Shares of Conatus Pharmaceuticals Inc (NASDAQ: CNAT) were higher by nearly 5 percent on Thursday, although shares initially surged higher by more than 30 percent following the announcement on Wednesday. Conatus announced results from its Phase II study of emricasan in 22 Portal Hypertension...

Shares of Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH) plunged nearly 80 percent on Wednesday, trading as low as $9.00 per share. The massive selloff is attributed to the company failing to meet the primary endpoint of statistical non-inferiority for IGNITE2 compared to levofloxacin. Here is a...